Wikidata entity: Q251347
C₂₁H₂₃ClFNO₂ (P274)
Quantities
| P4250 | defined daily dose | 3.3 |
| P4250 | defined daily dose | 8 |
| P2067 | mass | 375.140135 |
| P3780 | active ingredient in | ... | Q47521676 (Haldol) | Haldol |
| P233 | canonical SMILES | String | C1CN(CCC1(C2=CC=C(C=C2)Cl)O)CCCC(=O)C3=CC=C(C=C3)F | ??? |
| P373 | Commons category | String | Haloperidol | ??? |
| P1552 | has characteristic | ... | Q1517187 (bitterness) | bitterness |
| P527 | has part(s) | ... | Q627 (nitrogen) | nitrogen |
| P527 | has part(s) | ... | Q623 (carbon) | carbon |
| P527 | has part(s) | ... | Q629 (oxygen) | oxygen |
| P527 | has part(s) | ... | Q650 (fluorine) | fluorine |
| P527 | has part(s) | ... | Q688 (chlorine) | chlorine |
| P366 | has use | ... | Q12140 (medication) | medication |
| P31 | instance of | ... | Q113145171 (type of chemical entity) | type of chemical entity |
| P3493 | legal status (medicine) | ... | Q879952 (boxed warning) | boxed warning |
| P8026 | LiverTox likelihood score | ... | Q83284157 (LiverTox toxicity likelihood category B) | LiverTox toxicity likelihood category B |
| P1987 | MCN code | String | 2933.39.15 | ??? |
| P2175 | medical condition treated | ... | Q12135 (mental disorder) | mental disorder |
| P2175 | medical condition treated | ... | Q41112 (schizophrenia) | schizophrenia |
| P2175 | medical condition treated | ... | Q154430 (anxiety) | anxiety |
| P2175 | medical condition treated | ... | Q170082 (psychosis) | psychosis |
| P2175 | medical condition treated | ... | Q127076 (vomiting) | vomiting |
| P2175 | medical condition treated | ... | Q160796 (delirium) | delirium |
| P2175 | medical condition treated | ... | Q191779 (Tourette syndrome) | Tourette syndrome |
| P2175 | medical condition treated | ... | Q834047 (schizoaffective disorder) | schizoaffective disorder |
| P2175 | medical condition treated | ... | Q2157462 (schizophreniform disorder) | schizophreniform disorder |
| P361 | part of | ... | Q24460831 (response to haloperidol) | response to haloperidol |
| P361 | part of | ... | Q24460833 (cellular response to haloperidol) | cellular response to haloperidol |
| P129 | physically interacts with | ... | Q1949517 (5-hydroxytryptamine receptor 2A) | 5-hydroxytryptamine receptor 2A |
| P129 | physically interacts with | ... | Q2034004 (Dopamine receptor D2) | Dopamine receptor D2 |
| P129 | physically interacts with | ... | Q21109355 (5-hydroxytryptamine receptor 7) | 5-hydroxytryptamine receptor 7 |
| P129 | physically interacts with | ... | Q21110532 (Potassium voltage-gated channel subfamily H member 1) | Potassium voltage-gated channel subfamily H member 1 |
| P129 | physically interacts with | ... | Q21110867 (Dopamine receptor D1) | Dopamine receptor D1 |
| P129 | physically interacts with | ... | Q21110872 (Dopamine receptor D3) | Dopamine receptor D3 |
| P129 | physically interacts with | ... | Q21115043 (5-hydroxytryptamine receptor 1A) | 5-hydroxytryptamine receptor 1A |
| P129 | physically interacts with | ... | Q21115046 (5-hydroxytryptamine receptor 1D) | 5-hydroxytryptamine receptor 1D |
| P129 | physically interacts with | ... | Q21131500 (Dopamine receptor D5) | Dopamine receptor D5 |
| P129 | physically interacts with | ... | Q21497878 (Potassium inwardly-rectifying channel, subfamily J, member 6) | Potassium inwardly-rectifying channel, subfamily J, member 6 |
| P129 | physically interacts with | ... | Q21497939 (5-hydroxytryptamine (serotonin) receptor 7) | 5-hydroxytryptamine (serotonin) receptor 7 |
| P129 | physically interacts with | ... | Q4639596 (5-hydroxytryptamine receptor 2B) | 5-hydroxytryptamine receptor 2B |
| P129 | physically interacts with | ... | Q308856 (Dopamine receptor D4) | Dopamine receptor D4 |
| P129 | physically interacts with | ... | Q309513 (Histamine receptor H1) | Histamine receptor H1 |
| P3489 | pregnancy category | ... | Q28123617 (US pregnancy category C) | US pregnancy category C |
| P3489 | pregnancy category | ... | Q3679261 (Australian pregnancy category C) | Australian pregnancy category C |
| P769 | significant drug interaction | ... | Q568 (lithium) | lithium |
| P769 | significant drug interaction | ... | Q7739 (arsenic trioxide) | arsenic trioxide |
| P769 | significant drug interaction | ... | Q174259 (droperidol) | droperidol |
| P769 | significant drug interaction | ... | Q174723 (codeine) | codeine |
| P769 | significant drug interaction | ... | Q144085 (pimozide) | pimozide |
| P769 | significant drug interaction | ... | Q41576 (cocaine) | cocaine |
| P769 | significant drug interaction | ... | Q81225 (morphine) | morphine |
| P769 | significant drug interaction | ... | Q118551 (clarithromycin) | clarithromycin |
| P769 | significant drug interaction | ... | Q201872 (olanzapine) | olanzapine |
| P769 | significant drug interaction | ... | Q55434 (pethidine) | pethidine |
| P769 | significant drug interaction | ... | Q417597 (procainamide) | procainamide |
| P769 | significant drug interaction | ... | Q417909 (terfenadine) | terfenadine |
| P769 | significant drug interaction | ... | Q417915 (sufentanil) | sufentanil |
| P769 | significant drug interaction | ... | Q165399 (azithromycin) | azithromycin |
| P769 | significant drug interaction | ... | Q422438 (chloroquine) | chloroquine |
| P769 | significant drug interaction | ... | Q422970 ((±)-promethazine) | (±)-promethazine |
| P769 | significant drug interaction | ... | Q409672 ((RS)-citalopram) | (RS)-citalopram |
| P769 | significant drug interaction | ... | Q410011 (ondansetron) | ondansetron |
| P769 | significant drug interaction | ... | Q58375 (thioridazine) | thioridazine |
| P769 | significant drug interaction | ... | Q58396 (imipramine) | imipramine |
| P769 | significant drug interaction | ... | Q58397 (amitriptyline) | amitriptyline |
| P769 | significant drug interaction | ... | Q422244 (fluoxetine) | fluoxetine |
| P769 | significant drug interaction | ... | Q422418 ((RS)-sulpiride) | (RS)-sulpiride |
| P769 | significant drug interaction | ... | Q419394 (sevoflurane) | sevoflurane |
| P769 | significant drug interaction | ... | Q421381 (flecainide) | flecainide |
| P769 | significant drug interaction | ... | Q421937 ((RS)-hydroxyzine) | (RS)-hydroxyzine |
| P769 | significant drug interaction | ... | Q407535 (oxycodone) | oxycodone |
| P769 | significant drug interaction | ... | Q407541 (fentanyl) | fentanyl |
| P769 | significant drug interaction | ... | Q58614 (loxapine) | loxapine |
| P769 | significant drug interaction | ... | Q58713 (clomipramine) | clomipramine |
| P769 | significant drug interaction | ... | Q176533 (alfentanil) | alfentanil |
| P769 | significant drug interaction | ... | Q179996 ((RS)-methadone) | (RS)-methadone |
| P769 | significant drug interaction | ... | Q736270 (mefloquine) | mefloquine |
| P769 | significant drug interaction | ... | Q213511 (erythromycin) | erythromycin |
| P769 | significant drug interaction | ... | Q221361 (clozapine) | clozapine |
| P769 | significant drug interaction | ... | Q407592 (tramadol) | tramadol |
| P769 | significant drug interaction | ... | Q423437 (astemizole) | astemizole |
| P769 | significant drug interaction | ... | Q423498 (trimipramine) | trimipramine |
| P769 | significant drug interaction | ... | Q423757 (escitalopram) | escitalopram |
| P769 | significant drug interaction | ... | Q407721 (buprenorphine) | buprenorphine |
| P769 | significant drug interaction | ... | Q407972 (chlorpromazine) | chlorpromazine |
| P769 | significant drug interaction | ... | Q424238 (domperidone) | domperidone |
| P769 | significant drug interaction | ... | Q424940 (moxifloxacin) | moxifloxacin |
| P769 | significant drug interaction | ... | Q2622907 (periciazine) | periciazine |
| P769 | significant drug interaction | ... | Q947595 (halofantrine) | halofantrine |
| P769 | significant drug interaction | ... | Q976559 (sparfloxacin) | sparfloxacin |
| P769 | significant drug interaction | ... | Q10354103 (probucol) | probucol |
| P769 | significant drug interaction | ... | Q47495783 ((−)-selegiline) | (−)-selegiline |
| P769 | significant drug interaction | ... | Q71704041 ((E/Z)-doxepin) | (E/Z)-doxepin |
| P769 | significant drug interaction | ... | Q423292 (paliperidone) | paliperidone |
| P769 | significant drug interaction | ... | Q423308 (cabergoline) | cabergoline |
| P769 | significant drug interaction | ... | Q423364 (propranolol) | propranolol |
| P769 | significant drug interaction | ... | Q3712521 (dofetilide) | dofetilide |
| P769 | significant drug interaction | ... | Q3791612 (ibutilide) | ibutilide |
| P769 | significant drug interaction | ... | Q3896970 (pasireotide) | pasireotide |
| P769 | significant drug interaction | ... | Q408163 (anagrelide) | anagrelide |
| P769 | significant drug interaction | ... | Q408535 (quetiapine) | quetiapine |
| P769 | significant drug interaction | ... | Q408637 (dronedarone) | dronedarone |
| P769 | significant drug interaction | ... | Q228143 (zuclopenthixol) | zuclopenthixol |
| P769 | significant drug interaction | ... | Q269111 (apomorphine) | apomorphine |
| P769 | significant drug interaction | ... | Q300989 (levodopa) | levodopa |
| P769 | significant drug interaction | ... | Q3993743 ((Z)-Toremifene) | (Z)-Toremifene |
| P769 | significant drug interaction | ... | Q4890934 (bepridil) | bepridil |
| P769 | significant drug interaction | ... | Q5186964 (crizotinib) | crizotinib |
| P769 | significant drug interaction | ... | Q6821618 (mesoridazine) | mesoridazine |
| P769 | significant drug interaction | ... | Q7914515 (vandetanib) | vandetanib |
| P769 | significant drug interaction | ... | Q410061 (amiodarone) | amiodarone |
| P769 | significant drug interaction | ... | Q411188 (aripiprazole) | aripiprazole |
| P769 | significant drug interaction | ... | Q412221 (clonidine) | clonidine |
| P769 | significant drug interaction | ... | Q425120 (disopyramide) | disopyramide |
| P769 | significant drug interaction | ... | Q425137 (fingolimod) | fingolimod |
| P769 | significant drug interaction | ... | Q425295 (cisapride) | cisapride |
| P769 | significant drug interaction | ... | Q425729 (ivabradine) | ivabradine |
| P769 | significant drug interaction | ... | Q412443 (risperidone) | risperidone |
| P769 | significant drug interaction | ... | Q412496 (quinidine) | quinidine |
| P769 | significant drug interaction | ... | Q303646 (hydromorphone) | hydromorphone |
| P769 | significant drug interaction | ... | Q377270 (dihydrocodeine) | dihydrocodeine |
| P769 | significant drug interaction | ... | Q412621 (methyldopa) | methyldopa |
| P769 | significant drug interaction | ... | Q413050 (tetrabenazine) | tetrabenazine |
| P769 | significant drug interaction | ... | Q413581 (bromocriptine) | bromocriptine |
| P769 | significant drug interaction | ... | Q413591 (sotalol) | sotalol |
| P769 | significant drug interaction | ... | Q414463 (tapentadol) | tapentadol |
| P769 | significant drug interaction | ... | Q416206 (pentamidine) | pentamidine |
| P279 | subclass of | ... | Q156 (alcohols) | alcohols |
| P279 | subclass of | ... | Q193430 (heterocyclic compound) | heterocyclic compound |
| P2868 | subject has role | ... | Q35456 (essential medicine) | essential medicine |
| P2868 | subject has role | ... | Q208144 (antipsychotics) | antipsychotics |
| P2868 | subject has role | ... | Q575136 (antiemetic) | antiemetic |
| P2868 | subject has role | ... | Q50430254 (anti-dyskinesia agents) | anti-dyskinesia agents |
| P2868 | subject has role | ... | Q55427776 (female reproductive toxicant) | female reproductive toxicant |
| P2868 | subject has role | ... | Q72941151 (developmental toxicant) | developmental toxicant |
| P2868 | subject has role | ... | Q3271533 (dopamine antagonist) | dopamine antagonist |
| P2275 | World Health Organisation international non-proprietary name | Monolingualtext | haloperidol | ??? |
Why not click here or view trends?
log id: 1637678